1 High-Alert Medication Safety Fundamentals
Learn how to recognize high-alert medication risks, verify medications safely, use medication-specific safeguards, and respond to errors or signs of harm.
Recognize high-alert medication risks
can cause serious harm when used in error. Errors are not necessarily more frequent with these medications, but their consequences may be more severe. Examples include insulin, anticoagulants, opioids, antineoplastic agents, and concentrated electrolytes.
The exact high-alert list and required safeguards may vary by setting. Follow current facility policy and medication-specific guidance.
Verify orders and products
Before administering medication, verify that the order and product are clear and consistent. If information is incomplete or the product does not match the verified plan, pause and clarify with the appropriate prescriber, pharmacist, or clinical team. Do not infer an intended medication from the patient’s usual routine, ask another person to guess, or independently alter a product or treatment plan.
For a verified insulin order, check the product and concentration, dose, route, timing, glucose, and relevant meal status. Use the specific safeguards required for concentrated insulin products. If an insulin order states only “10 units” without identifying the insulin or route, hold the dose and clarify the order before administration.
Before an antineoplastic medication is administered, resolve any mismatch between the patient, dose, or route on the product label and the verified treatment plan with the appropriate oncology and pharmacy team. Follow required hazardous-drug handling procedures and use required protective equipment.
Reduce selection and storage risks
Use storage practices required by facility policy to reduce selection errors. Secure high-risk products and, where specified, segregate products or concentrations. Keep labels visible, control access as required, and select the exact product and strength. Follow specific storage rules for products such as concentrated electrolytes and insulin.
Use independent checks correctly
A required means the second clinician independently verifies the specified elements before administration. Depending on the policy, these may include the patient, medication, dose, concentration, calculation, route, pump settings, and line. A second clinician merely agreeing with the first person’s work, signing after an infusion has started, or assuming a pharmacy check replaces bedside verification does not meet that requirement.
Use double-checks as directed by policy. They are one safeguard, not a substitute for sound system design and other checks.
Respond to signs of medication-related harm
If a patient receiving an anticoagulant develops new bleeding from an IV site and feels faint, promptly assess severity and possible instability. Follow the relevant hold or escalation protocol and notify the appropriate clinician. Monitoring depends on the particular drug and clinical context; do not assume one laboratory test applies to every anticoagulant.
If a patient who received an opioid becomes difficult to rouse and has slow, shallow breathing, promptly assess and support the patient, activate emergency assistance as indicated, and follow the opioid-rescue protocol, including when indicated. Continue monitoring because may not provide lasting reversal.
Handle concentrated electrolytes safely
Do not administer concentrated injectable potassium chloride by IV push. If it is requested by that route, stop and urgently clarify the order through the appropriate clinical chain. Do not improvise by administering it slowly through a central line or diluting it at the bedside for IV push. Use only approved preparations, routes, rates, and pump safeguards under facility policy.
Respond to medication errors
When a patient receives more medication than the order specified, promptly assess the patient and take immediate safety actions. Notify the appropriate clinician and pharmacist, then follow clinical monitoring and organizational reporting procedures. Document care and findings accurately in the health record; use the safety-reporting system separately according to policy. Do not wait for symptoms before escalating, alter the medication record to match the order, or substitute an incident report for patient care.
Coordinate safeguards across the medication process
Safe use of depends on clear orders, careful verification of the patient and product, appropriate monitoring, secure storage, and safeguards matched to the medication and setting. When an order or product is unclear, pause and clarify. If an error or suspected harm occurs, assess and protect the patient, escalate promptly, and follow established procedures.